129 related articles for article (PubMed ID: 36054582)
21. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
[TBL] [Abstract][Full Text] [Related]
22. [Multisystemic amyloidosis. Clinical study of 39 patients in Lebanon].
Saba M; Tohmé A; Abadjian G; Haddad F; Ghayad E
Presse Med; 2005 May; 34(9):640-6. PubMed ID: 15988337
[TBL] [Abstract][Full Text] [Related]
23. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
[TBL] [Abstract][Full Text] [Related]
24. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
[TBL] [Abstract][Full Text] [Related]
25. Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers.
Rezk T; Lachmann HJ; Fontana M; Naharro AM; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Foard D; Lane T; Youngstein T; Wechalekar AD; Hawkins PN; Gillmore JD
Br J Haematol; 2019 Aug; 186(3):460-470. PubMed ID: 31124579
[TBL] [Abstract][Full Text] [Related]
26. Sequential Liver, Kidney, and Autologous Stem Cell Transplant for AL Amyloidosis: A Case Report.
Sevmis M; Aktas S; Alkara U; Kilercik H; Göksoy HS; Uyar M; Sevmis S
Transplant Proc; 2022; 54(1):197-201. PubMed ID: 34953597
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.
Montseny JJ; Kleinknecht D; Meyrier A; Vanhille P; Simon P; Pruna A; Eladari D
Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation.
Havasi A; Doros G; Sanchorawala V
Am J Hematol; 2018 May; 93(5):E129-E132. PubMed ID: 29430701
[No Abstract] [Full Text] [Related]
29. Renal Involvement in Systemic Amyloidosis Caused by Monoclonal Immunoglobulins.
Karam S; Leung N
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1069-1079. PubMed ID: 33099424
[TBL] [Abstract][Full Text] [Related]
30. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis.
Yao Y; Wang SX; Zhang YK; Qu Z; Liu G; Zou WZ
Nephrol Dial Transplant; 2013 Mar; 28(3):689-97. PubMed ID: 23182813
[TBL] [Abstract][Full Text] [Related]
31. Secondary amyloidosis in ankylosing spondylitis.
Dönmez S; Pamuk ÖN; Pamuk GE; Aydoğdu E; Inman R
Rheumatol Int; 2013 Jul; 33(7):1725-9. PubMed ID: 23283540
[TBL] [Abstract][Full Text] [Related]
32. Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney.
Eirin A; Irazabal MV; Gertz MA; Dispenzieri A; Lacy MQ; Kumar S; Sethi S; Nasr SH; Cornell LD; Fidler ME; Fervenza FC; Leung N
Nephrol Dial Transplant; 2012 Mar; 27(3):1097-101. PubMed ID: 22067518
[TBL] [Abstract][Full Text] [Related]
33. Amyloidosis and the Kidney: An Update.
Nader R; Angel-Korman A; Havasi A
Semin Nephrol; 2022 Nov; 42(6):151343. PubMed ID: 37148782
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and clinical outcomes of living renal donors in Hong Kong.
Hong YL; Yee CH; Leung CB; Teoh JY; Kwan BC; Li PK; Hou SS; Ng CF
Hong Kong Med J; 2018 Feb; 24(1):11-17. PubMed ID: 29284159
[TBL] [Abstract][Full Text] [Related]
35. Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report.
Al-Zoairy R; Viveiros A; Zoller H; Schneeberger S; Oberhuber G; Gunsilius E; Tilg H; Wolf D; Rudzki JD
J Med Case Rep; 2020 Oct; 14(1):201. PubMed ID: 33099313
[TBL] [Abstract][Full Text] [Related]
36. [AL amyloidosis, from diagnosis to treatment].
Villesuzanne C; Jaccard A; Nicol M
Rev Prat; 2020 Dec; 70(10):1137-1141. PubMed ID: 33739663
[TBL] [Abstract][Full Text] [Related]
37. Impact of body mass index on progression of primary immunoglobulin a nephropathy.
Nagaraju SP; Rangaswamy D; Mareddy AS; Prasad S; Kaza S; Shenoy S; Saraf K; Attur RP; Parthasarathy R; Kosuru S; Mateti UV; Guddattu V; Koulmane Laxminarayana SL
Saudi J Kidney Dis Transpl; 2018; 29(2):318-325. PubMed ID: 29657199
[TBL] [Abstract][Full Text] [Related]
38. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
39. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.
Hasib Sidiqi M; Gertz MA
Blood Cancer J; 2021 May; 11(5):90. PubMed ID: 33993188
[TBL] [Abstract][Full Text] [Related]
40. Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor.
Rezk T; Lachmann HJ; Fontana M; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Foard D; Lane T; Youngstein T; Wechalekar AD; Bass P; Hawkins PN; Gillmore JD
Kidney Int; 2017 Dec; 92(6):1476-1483. PubMed ID: 28729034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]